30 Patent Results (12 families)
Make Note

Novel Compounds As Calcium Channel Blockers

  • Published: Apr 8, 2010
  • Filed: Oct 1, 2009
  • Earliest Priority: Oct 02 2008
  • Family: 9
  • Cited Works: 19
  • Cited by: 13
  • Cites: 5
  • Additional Info: Cited Works Full text Published
  • Applicant: Abbott Lab, Bhatia Pramila A, Doherty George A, Drizin Irene, Mack Helmut, Perner Richard J, Stewart Andrew O, Zhang Qing Wei
Patent Application
WO 2010/039947 A1
111-463-137-377-518

Novel Benzenesulfonamides As Calcium Channel Blockers

  • Published: Jul 22, 2010
  • Filed: Jan 14, 2010
  • Earliest Priority: Jan 15 2009
  • Family: 31
  • Cited Works: 79
  • Cited by: 15
  • Cites: 6
  • Additional Info: Cited Works Full text Published
  • Applicant: Abbott Lab, Zhang Qingwei, Stewart Andrew O, Xia Zhiren
Patent Application
WO 2010/083264 A1
064-662-334-018-281

2-phenylethylamino Derivatives As Calcium And/or Sodium Channel Modulators

  • Published: Dec 21, 2010
  • Filed: Nov 29, 2006
  • Earliest Priority: Dec 22 2005
  • Family: 42
  • Cited Works: 99
  • Cited by: 4
  • Cites: 70
  • Additional Info: Cited Works Full text Published
  • Owner: Newron Pharmaceuticals S.p.a
  • Applicant: Newron Pharm Spa
Granted Patent
US 7855227 B2
101-601-354-656-521

Lactam Acetamides As Calcium Channel Blockers

  • Published: Sep 22, 2011
  • Filed: Mar 10, 2011
  • Earliest Priority: Mar 18 2010
  • Family: 3
  • Cited Works: 76
  • Cited by: 13
  • Cites: 8
  • Additional Info: Cited Works Full text Published
  • Applicant: Abbott Lab, Drizin Irene, Doherty George, Bhatia Pramila A, Stewart Andrew O
Patent Application
WO 2011/115813 A1
125-155-547-433-969

Compounds As Calcium Channel Blockers

  • Published: Oct 25, 2011
  • Filed: Oct 1, 2009
  • Earliest Priority: Oct 02 2008
  • Family: 9
  • Cited Works: 77
  • Cited by: 6
  • Cites: 6
  • Additional Info: Cited Works Full text Published
  • Owner: Abbvie Deutschland Gmbh & Co Kg, Abbvie Inc, Abbott Gmbh & Co. Kg, Abbott Laboratories
  • Applicant: Abbott Lab, Abbott Gmbh & Co Kg
Granted Patent
US 8044069 B2
167-963-325-402-701

Substituted Octahydrocyclopenta[c]Pyrroles As Calcium Channel Modulators

  • Published: Dec 1, 2011
  • Filed: May 24, 2011
  • Earliest Priority: May 25 2010
  • Family: 4
  • Cited Works: 83
  • Cited by: 4
  • Cites: 3
  • Additional Info: Cited Works Full text Published
  • Applicant: Abbott Lab, Searle Xenia B, Yeung Ming C, Schrimpf Michael R
Patent Application
WO 2011/149993 A2
169-041-371-375-080

Novel Substituted Octahydrocyclopenta [c]Pyrrol-4-amines As Calcium Channel Blockers

  • Published: Dec 1, 2011
  • Filed: May 24, 2011
  • Earliest Priority: May 25 2010
  • Family: 3
  • Cited Works: 89
  • Cited by: 7
  • Cites: 9
  • Additional Info: Cited Works Full text Published
  • Applicant: Abbott Lab, Searle Xenia B, Yeung Ming C, Didomenico Stanley, Stewart Andrew O, Darczak Daria, Schrimpf Michael R, Rozema Michael J
Patent Application
WO 2011/149995 A1
038-977-653-419-334

Pyrazolo[1,5-a]Pyrimidine-carbonyl-piperazine Derivatives

  • Published: Jan 10, 2012
  • Filed: Jul 15, 2009
  • Earliest Priority: Jul 17 2008
  • Family: 12
  • Cited Works: 3
  • Cited by: 0
  • Cites: 50
  • Additional Info: Cited Works Full text Published
  • Owner: Convergence Pharmaceuticals Limited, Glaxo Group Limited
  • Applicant: Heer Jag Paul, Norton David, Ward Simon E, Convergence Pharmaceuticals
Granted Patent
US 8093249 B2
012-146-072-764-286

Substituted Pyrrolo [1,2-a] Pyrazines As Calcium Channel Blockers

  • Published: Jan 24, 2012
  • Filed: Jan 14, 2010
  • Earliest Priority: Jan 15 2009
  • Family: 31
  • Cited Works: 71
  • Cited by: 4
  • Cites: 7
  • Additional Info: Cited Works Full text Published
  • Owner: Abbvie Inc, Abbott Laboratories
  • Applicant: Zhang Qingwei, Stewart Andrew O, Xia Zhiren, Abbott Lab
Granted Patent
US 8101614 B2
016-235-678-228-381

Substituted Octahydrocyclopenta[c]Pyrrol-4-amines As Calcium Channel Blockers

  • Published: Mar 6, 2012
  • Filed: Nov 25, 2009
  • Earliest Priority: Nov 26 2008
  • Family: 26
  • Cited Works: 88
  • Cited by: 5
  • Cites: 14
  • Additional Info: Cited Works Full text Published
  • Owner: Abbvie Inc, Abbott Laboratories
  • Applicant: Stewart Andrew O, Searle Xenia B, Darczak Daria, Yeung Ming Clinton, Didomenico Stanley, Abbott Lab
Granted Patent
US 8129417 B2
173-286-548-211-664
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback